Visual analogue scales (EVAs)
OtherThis scale measures the pain intensity.
NCT Number: NCT01402830
The purpose of this study is to evaluate the relationship between cancer pain and risk of depression among cancer patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
This is a retrospective observational and case-control multicenter study. The main objective of this study is determine the degree of association between cancer pain and depression by impact assessment of adequate control of pain associated with cancer risk depression in patients attending the Oncology Unit. The assessment of pain intensity will be performed by using visual analogue scales (EVAs) and verbal descriptive scales, as an observational study, not limit or modify the use of any drug. The patients included in this study have a medical history of cancer pain and mild depression (Beck = 8). The controls are patients with history of cancer pain and mild or absent depression (Beck = 7). n/a
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This scale measures the pain intensity.
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Janssen-Cilag, S.A.
Industry
DPRESS Study. Case-control Study in Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05051735
Cancer, Cancer Pain
Milan, Italy
View Trial DetailsNCT07262151
Anxiety, Anxiety Disorders
Yozgat, Merkez, Turkey (Türkiye)
View Trial DetailsNCT05348174
Anxiety Disorders, Behavior
Clemson, South Carolina, United States
View Trial DetailsNCT06590389
Anxiety Disorders, Cancer
Istanbul, Üsküdar, Turkey (Türkiye)
View Trial Details